Novo Nordisk
Business
OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. The company will merge Orchestra's team and…
NVIDIA Partners With Novo Nordisk and DCAI on Drug Discovery
NVIDIA has announced a partnership with Novo Nordisk and DCAI aimed at advancing drug discovery. The announcement was published on NVIDIA's newsroom on 28 September 2026…